- Home
- CI vs APP Comparison
CI vs APP Comparison
Compare CI & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CI
- APP
- Stock Information
- Founded
- CI 1792
- APP 2012
- Country
- CI United States
- APP United States
- Employees
- CI N/A
- APP N/A
- Industry
- CI Medical Specialities
- APP EDP Services
- Sector
- CI Health Care
- APP Technology
- Exchange
- CI Nasdaq
- APP Nasdaq
- Market Cap
- CI 81.7B
- APP 81.0B
- IPO Year
- CI N/A
- APP 2021
- Fundamental
- Price
- CI $333.71
- APP $331.82
- Analyst Decision
- CI Strong Buy
- APP Buy
- Analyst Count
- CI 17
- APP 20
- Target Price
- CI $384.29
- APP $400.11
- AVG Volume (30 Days)
- CI 1.6M
- APP 7.3M
- Earning Date
- CI 05-02-2025
- APP 05-07-2025
- Dividend Yield
- CI 1.81%
- APP N/A
- EPS Growth
- CI 46.10
- APP 232.34
- EPS
- CI 17.99
- APP 5.53
- Revenue
- CI $255,368,000,000.00
- APP $5,135,154,000.00
- Revenue This Year
- CI $5.06
- APP $21.91
- Revenue Next Year
- CI $4.65
- APP $21.63
- P/E Ratio
- CI $18.52
- APP $61.35
- Revenue Growth
- CI 23.96
- APP 41.63
- 52 Week Low
- CI $262.03
- APP $60.67
- 52 Week High
- CI $370.83
- APP $525.15
- Technical
- Relative Strength Index (RSI)
- CI 52.42
- APP 64.80
- Support Level
- CI $330.21
- APP $290.96
- Resistance Level
- CI $337.25
- APP $307.27
- Average True Range (ATR)
- CI 7.16
- APP 16.73
- MACD
- CI -0.92
- APP 9.39
- Stochastic Oscillator
- CI 27.79
- APP 86.66
About CI The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max, and gaming studios, which develop mobile games. AppLovin announced in February 2025 its plans to divest from the lower-margin gaming studios to focus exclusively on the ad tech platform. AppLovin's primary tool for future growth is Axon 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.